Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Cardinal

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Hepatology (Baltimore, Md.)|February 5, 2010
Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injuryShinya Ueki, Rajeev Dhupar, Jon Cardinal, et al.
Blood|March 26, 2010
mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPSHeth R Turnquist, Jon Cardinal, Camila Macedo, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 18, 2009
Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 casesJon Cardinal, Michael E de Vera, James W Marsh, et al.
The Journal of Biological Chemistry|October 13, 2010
High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activityJohn Evankovich, Sung W Cho, Ruilin Zhang, et al.
Shock (Augusta, Ga.)|September 22, 2010
Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injuryRajeev Dhupar, John R Klune, John Evankovich, et al.
Surgery|July 25, 2009
Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injuryKee-Hwan Kim, Rajeev Dhupar, Shinya Ueki, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 30, 2012
Interferon regulatory factor-2 is protective against hepatic ischemia-reperfusion injuryJohn R Klune, Rajeev Dhupar, Shoko Kimura, et al.
Hepatology (Baltimore, Md.)|December 21, 2011
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver diseaseSrinevas K Reddy, Jennifer L Steel, Hui-Wei Chen, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Hepatology (Baltimore, Md.)|February 5, 2010
Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injuryShinya Ueki, Rajeev Dhupar, Jon Cardinal, et al.
Blood|March 26, 2010
mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPSHeth R Turnquist, Jon Cardinal, Camila Macedo, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 18, 2009
Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 casesJon Cardinal, Michael E de Vera, James W Marsh, et al.
The Journal of Biological Chemistry|October 13, 2010
High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activityJohn Evankovich, Sung W Cho, Ruilin Zhang, et al.
Shock (Augusta, Ga.)|September 22, 2010
Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injuryRajeev Dhupar, John R Klune, John Evankovich, et al.
Surgery|July 25, 2009
Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injuryKee-Hwan Kim, Rajeev Dhupar, Shinya Ueki, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 30, 2012
Interferon regulatory factor-2 is protective against hepatic ischemia-reperfusion injuryJohn R Klune, Rajeev Dhupar, Shoko Kimura, et al.
Hepatology (Baltimore, Md.)|December 21, 2011
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver diseaseSrinevas K Reddy, Jennifer L Steel, Hui-Wei Chen, et al.
Pageof 2